St George's, University of London - Nosing ahead

July 9, 2009

Researchers at St George's, University of London have been awarded £4.3 million by the Wellcome Trust for the development of a new class of drugs that aims to target the root cause, instead of the symptoms, of asthma and allergies. The research team, led by Clive Robinson, professor of respiratory cell science, has identified novel, drug-like chemical compounds that combat asthma and allergic diseases of the nose, eyes and skin. The St George's team will work with colleagues from the University of Manchester to develop a drug for clinical trials in the next few years.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments